CEA and CA 19-9 as prognostic indexes in colorectal cancer

Hepato-Gastroenterology

Volumn 46, Issue 26, 1999, Pages 905-908

  Manoukian Forones, Nora ^a   Tanaka, Marcelo ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

CA 19 9; CEA; Colorectal cancer; Prognostic value

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER MORTALITY; CANCER RECURRENCE; COLORECTAL CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0032962156     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. 1 Gold P, Freedman SO: Demonstration of tumor-specific antigens in human colonie carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121:439-462.
2. 2 Torosian MH, Daly JM: An evaluation of the clinical usefulness of CEA in colorectal cancer. Oncology 1991; 5:41-44.
3. 3 Hohenberger P, Schalg P, Gerneth T, Herfather C: Pre-and post-operative carcinoembryonic antigen determination in hepatic resection for colorectal metastases. Ann Surg 1994; 219:135-143.
4. 4 Steele G, Ellenberg S, Ramming K, et al: CEA monitoring among patients in multi-institutional adjuvant GI therapy protocols. Ann Surg 1982; 196:162-169.
5. 5 Wanebo HJ, Rao B, Pinsky CM, et al: Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978; 299:448-451.
6. 6 Wolmark N, Fisher B, Wieand HS, et al: The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Ann Surg 1984; 199:375-381.
7. 7 Sener SF, Imperato JP, Chmiel J, Fremgen A, Sylvester J: The use of cancer registry data to study preoperative carcinoembryonic antigen level as an indicator of survival in colorectal cancer. CA 1989; 39:50-57.
8. 8 Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P: Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Mol Genet 1979; 5:957-972.
9. 9 Jalanko H, Kuusela P, Roberts P, Sipponem P, et al: Comparison of a new tumor marker, CA19-9, with alfafetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol 1984; 37:218-222.
10. 10 Ueda T, Etsuji S, Urakawa T: The clinicopathologic features of serum CA19-9 positive colorectal cancers. Surgery Today 1994; 24:518-525.
11. 11 Diez M, Cerdan FJ, Pollan M, Ortega MD, Martinez S, et al: Prognostic significance of preoperative serum CA19-9 assay in patients with colorectal carcinoma. Anticancer Res 1994; 14:2819-2825.
12. 12 Arends JW, Wiggers T, Verstunem C, Hilgers J, Bosman FT: Gastrointestinal cancer-associated antigen (GICA) immunoreactivity in colorectal carcinoma in relation to patients survival. Int J Cancer 1984; 34:193-196.
13. 13 Kouri M, Pyrhonen S, Kuusela P: Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma. Journal of Surgical Oncology 1992; 49:78-85.
14. 14 Tsavaris N, Vonorta K, Tsoutsos H, Kozatsani-Halividi D, Mylonakis N, et al: Carcinoembryonic antigen (CEA), alpha-fetoprotein, CA19-9 and CA125 in advanced colorectal cancer. Int J Biol Markers 1993; 8:88-93.
15. 15 Filella X, Molina R, Pique JM: Prognostic value of CA19-9 levels in colorectal cancer. Ann Surg 1992; 216:55-59.
16. 16 Kuusela P, Jalanko H, Roberts P, et al: Comparison of CA19-9 and carcinoembryonic antigen levels in the serum of patients with colorectal diseases. Br J Cancer 1984; 49:135-139.
17. 17 Fernandez-Fernandez L, Tejero E, Tieso A: Significance of CA 72-4 in colorectal carcinoma. Comparison with CEA and CA19-9. European Journal of Surgical Oncology 1995; 21:388-390.
18. 18 Chu DZJ, Erickson CA, Russell P, Thompson C, Lang NP, Broadwater RJ, Westbrook KC: Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Serum levels before and after resection and before recurrence. Arch Surg 1991; 126:314-316.
19. 19 Kouri M, Nordling S, Kuusela P: Poor prognostic associated with elevated serum CA19-9 level in advanced colorectal carcinoma, independent of DNA ploidy or SPF. Eur J Cancer 1993; 12:1691-1696.